Light and moderate intensity physical activity are associated with better ambulation, quality of life, and vascular measurements in patients with claudication.

Exercise Inflammation Microvascular Near-infrared spectroscopy Peripheral artery disease Physical activity monitoring

Journal

Journal of vascular surgery
ISSN: 1097-6809
Titre abrégé: J Vasc Surg
Pays: United States
ID NLM: 8407742

Informations de publication

Date de publication:
05 2022
Historique:
received: 24 03 2021
accepted: 21 12 2021
pubmed: 10 1 2022
medline: 27 4 2022
entrez: 9 1 2022
Statut: ppublish

Résumé

We sought to determine whether patients with claudication who reported performing either light intensity physical activity (LPA) or moderate-to-vigorous intensity physical activity (MVPA) would have higher levels of objectively determined physical activity and better physical function, health-related quality of life (HRQoL), and vascular measures, consisting of exercise time to minimum calf muscle oxygen saturation (StO A total of 269 patients were assessed using the Johnson Space Center physical activity scale. The patients were grouped according to whether they performed no physical activities (n = 75), LPAs (n = 140), or MVPAs (n = 54). The primary measurements were the total daily steps obtained from a step activity monitor worn for 1 week, peak walking time obtained from a treadmill test, physical function score on the Medical Outcomes Study short-form 36-item survey to assess HRQoL, and high-sensitivity C-reactive protein. The total daily steps was significantly different among the groups. Both the LPA group (mean ± standard deviation, 7878 ± 2808 steps/d) and the MVPA group (mean, 8551 ± 3365 steps/d) had taken more daily steps (P < .01) than had the sedentary group (mean, 3323 ± 986 steps/d). The treadmill peak walking time was significantly different among the three groups. Both the LPA group (433 ± 296 seconds) and the MVPA group (548 ± 300 seconds) had had a greater peak walking time (P < .01) than that of the sedentary group (302 ± 210 seconds). The physical function score was also significantly different among the groups. The LPA group (44% ± 20%) and MVPA group (58% ± 19%) both had had higher scores (P < .01) than the sedentary group (36% ± 20%). In addition, the exercise time to the minimum calf muscle StO Patients with claudication who reported performing LPA had greater amounts of objectively determined physical activity levels and better physical function, HRQoL, and vascular measures than those who reported being physically sedentary. Furthermore, these favorable results associated with LPA were even more pronounced for the patients who performed MVPA compared with those who were sedentary. The clinical significance is that our results have shown that engaging in any physical activity, even at relatively light intensity, is associated with favorable health and vascular measures for patients with claudication.

Identifiants

pubmed: 34999217
pii: S0741-5214(21)02751-8
doi: 10.1016/j.jvs.2021.12.071
pmc: PMC9038648
mid: NIHMS1769824
pii:
doi:

Substances chimiques

C-Reactive Protein 9007-41-4

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

1739-1749

Subventions

Organisme : NIA NIH HHS
ID : R01 AG016685
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG024296
Pays : United States

Informations de copyright

Copyright © 2022 Society for Vascular Surgery. Published by Elsevier Inc. All rights reserved.

Références

JAMA. 1963 Sep 21;185:914-9
pubmed: 14044222
J Vasc Surg. 2008 Sep;48(3):644-9
pubmed: 18572363
Med Sci Sports Exerc. 2021 Apr 1;53(4):732-739
pubmed: 32991346
Med Sci Sports Exerc. 2018 Jun;50(6):1315-1322
pubmed: 29381649
Circulation. 2012 Dec 11;126(24):2890-909
pubmed: 23159553
Age (Dordr). 2016 Jun;38(3):64
pubmed: 27273077
JAMA. 2018 Nov 20;320(19):2020-2028
pubmed: 30418471
Qual Life Res. 2014 Apr;23(3):977-89
pubmed: 24081873
N Engl J Med. 1992 Feb 6;326(6):381-6
pubmed: 1729621
Sports Med Open. 2015;1(1):37
pubmed: 26512340
J Vasc Surg. 2008 Jan;47(1):117-22
pubmed: 18178462
Vasc Med. 2008 Feb;13(1):15-24
pubmed: 18372434
JAMA Intern Med. 2019 Aug 01;179(8):1105-1112
pubmed: 31141585
Phys Ther. 2017 May 01;97(5):581-588
pubmed: 28339904
Circulation. 2019 Jan 22;139(4):e10-e33
pubmed: 30586765
J Vasc Surg. 2005 Oct;42(4):702-9
pubmed: 16242558
J Am Heart Assoc. 2015 Jul 28;4(7):
pubmed: 26219563
N Engl J Med. 1988 Dec 29;319(26):1701-7
pubmed: 3205267
MMWR Morb Mortal Wkly Rep. 2000 Jun 30;49(25):560-5
pubmed: 10921494
Circulation. 2006 Mar 21;113(11):e463-654
pubmed: 16549646
J Gerontol. 1966 Oct;21(4):556-9
pubmed: 5918309
J Am Heart Assoc. 2014 Sep 18;3(5):e001107
pubmed: 25237048
J Vasc Surg. 2008 Nov;48(5):1238-44
pubmed: 18771878
Int J Behav Med. 2015 Feb;22(1):70-6
pubmed: 24715636
Med Sci Sports Exerc. 1991 Apr;23(4):402-8
pubmed: 2056896
Med Sci Sports Exerc. 1982;14(5):377-81
pubmed: 7154893
Circulation. 2006 Jul 18;114(3):242-8
pubmed: 16818814
JAMA. 2021 Apr 6;325(13):1266-1276
pubmed: 33821898
JAMA. 2001 Oct 3;286(13):1599-606
pubmed: 11585483
Vasc Med. 2008 Aug;13(3):209-15
pubmed: 18687757
J Gerontol. 1994 Mar;49(2):M85-94
pubmed: 8126356
J Gerontol A Biol Sci Med Sci. 1995 Jul;50(4):M211-5
pubmed: 7614243
J Vasc Surg. 2007 Jan;45 Suppl S:S5-67
pubmed: 17223489
Vasc Med. 1997 Nov;2(4):286-91
pubmed: 9575600
Vasc Endovascular Surg. 2007 Dec-2008 Jan;41(6):481-9
pubmed: 18166628
Lancet. 2013 Oct 19;382(9901):1329-40
pubmed: 23915883
Med Sci Sports Exerc. 1990 Dec;22(6):863-70
pubmed: 2287267
Ann Vasc Surg. 2019 Feb;55:112-121
pubmed: 30114505
Ann Intern Med. 2009 May 5;150(9):604-12
pubmed: 19414839
Med Care. 1992 Jun;30(6):473-83
pubmed: 1593914
JAMA. 2001 May 16;285(19):2486-97
pubmed: 11368702
Vasc Endovascular Surg. 2008 Apr-May;42(2):101-12
pubmed: 18390972
Ann Intern Med. 2017 Oct 03;167(7):465-475
pubmed: 28892811
J Am Geriatr Soc. 1998 Jun;46(6):706-11
pubmed: 9625185
Am J Kidney Dis. 2002 Feb;39(2 Suppl 1):S1-266
pubmed: 11904577
J Vasc Surg. 2007 Dec;46(6):1208-14
pubmed: 17919876
J Clin Epidemiol. 1990;43(6):597-606
pubmed: 2189949
Med Sci Sports Exerc. 1995 Apr;27(4):599-606
pubmed: 7791593

Auteurs

Andrew W Gardner (AW)

Department of Physical Medicine and Rehabilitation, Penn State College of Medicine, Hershey, Pa; University of Oklahoma Health Sciences Center, Oklahoma City, Okla. Electronic address: agardner4@pennstatehealth.psu.edu.

Polly S Montgomery (PS)

Department of Physical Medicine and Rehabilitation, Penn State College of Medicine, Hershey, Pa; University of Oklahoma Health Sciences Center, Oklahoma City, Okla.

Ming Wang (M)

Department of Public Health Sciences, Penn State College of Medicine, Hershey, Pa.

Biyi Shen (B)

Department of Public Health Sciences, Penn State College of Medicine, Hershey, Pa.

Azhar Afaq (A)

Inpatient Physician Associates, Fort Worth, Tex.

Aman Khurana (A)

Prairie Cardiovascular Consultants, Springfield, Ill.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH